{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:23Z","timestamp":1793390843147,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10787-026-02117-5","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:12:45Z","timestamp":1769749965000},"page":"1005-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polycystic ovary syndrome (PCOS): current insights, emerging therapeutics, and future treatment strategies"],"prefix":"10.1007","volume":"34","author":[{"given":"Mitali","family":"Panchpuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anglina","family":"Kisku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Painuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"4","key":"2117_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mefs.2018.04.005","volume":"23","author":"Z Abasian","year":"2018","unstructured":"Abasian Z, Rostamzadeh A, Mohammadi M, Hosseini M, Rafieian-kopaei M, Middle East Fertility Society (2018) A review on role of medicinal plants in polycystic ovarian syndrome: pathophysiology, neuroendocrine signaling, therapeutic status and future prospects. Middle East Fertil Soc J 23(4):255\u2013262. https:\/\/doi.org\/10.1016\/j.mefs.2018.04.005","journal-title":"Middle East Fertil Soc J"},{"key":"2117_CR200","doi-asserted-by":"publisher","unstructured":"Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T (2020) A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. In: Therapeutic advances in endocrinology and metabolism, vol 11. SAGE Publications Ltd. https:\/\/doi.org\/10.1177\/2042018820938305","DOI":"10.1177\/2042018820938305"},{"key":"2117_CR201","doi-asserted-by":"publisher","unstructured":"Abdalla MA, Shah N, Deshmukh H, Sahebkar A, \u00d6stlundh L, Al-Rifai RH, Atkin SL, Sathyapalan T (2022) Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. In: Therapeutic advances in endocrinology and metabolism, vol 13. SAGE Publications Ltd. https:\/\/doi.org\/10.1177\/20420188221127142","DOI":"10.1177\/20420188221127142"},{"issue":"4","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5114\/pm.2020.101948","volume":"19","author":"IA Abdelazim","year":"2021","unstructured":"Abdelazim IA, Amer OO, Farghali M (2021) Common endocrine disorders associated with the polycystic ovary syndrome. Przegl Menopauzalny 19(4):179\u2013183. https:\/\/doi.org\/10.5114\/pm.2020.101948","journal-title":"Przegl Menopauzalny"},{"key":"2117_CR215","doi-asserted-by":"publisher","unstructured":"Abdel-Maboud M, Menshawy A, Hasabo EA, Abdelraoof MI, Alshandidy M, Eid M, Menshawy E, Outani O, Menshawy A (2021) The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: a network meta-analysis of 101 randomized trials. In: PLOS ONE, vol 16, no. 7. Public Library of Science. https:\/\/doi.org\/10.1371\/journal.pone.0254412","DOI":"10.1371\/journal.pone.0254412"},{"issue":"3","key":"2117_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00404-020-05951-2","volume":"303","author":"S Abraham Gnanadass","year":"2021","unstructured":"Abraham Gnanadass S, Divakar Prabhu Y, Valsala Gopalakrishnan A, Springer Science and Business Media Deutschland GmbH (2021) Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet 303(3):631\u2013643. https:\/\/doi.org\/10.1007\/s00404-020-05951-2","journal-title":"Arch Gynecol Obstet"},{"key":"2117_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34183","author":"A Adone","year":"2023","unstructured":"Adone A, Fulmali DG (2023) Polycystic ovarian syndrome in adolescents. Cureus. https:\/\/doi.org\/10.7759\/cureus.34183","journal-title":"Cureus"},{"issue":"3","key":"2117_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5653\/cerm.2023.05897","volume":"50","author":"S Afrine","year":"2023","unstructured":"Afrine S, Haque JA, Morshed MS, Banu H, Hossain A, Hasanat MA (2023) Ovarian volume is more closely related to the different manifestations of polycystic ovary syndrome than follicle number per ovary. Clin Exp Reprod Med 50(3):200\u2013205. https:\/\/doi.org\/10.5653\/cerm.2023.05897","journal-title":"Clin Exp Reprod Med"},{"issue":"6","key":"2117_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2023.E16957","volume":"9","author":"T Akter","year":"2023","unstructured":"Akter T, Zahan MS, Nawal N, Rahman MH, Tanjum TN, Arafat KI, Moni A, Islam MN, Uddin MJ (2023) Potentials of curcumin against polycystic ovary syndrome: pharmacological insights and therapeutic promises. Heliyon 9(6):e16957. https:\/\/doi.org\/10.1016\/J.HELIYON.2023.E16957","journal-title":"Heliyon"},{"key":"2117_CR221","doi-asserted-by":"publisher","unstructured":"Alalami H, Sathyapalan T, Atkin SL (2019) Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome. In: Therapeutic advances in endocrinology and metabolism, vol 10. SAGE Publications Ltd. https:\/\/doi.org\/10.1177\/2042018818805674","DOI":"10.1177\/2042018818805674"},{"issue":"8","key":"2117_CR7","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1210\/clinem\/dgab232","volume":"106","author":"BH Al Wattar","year":"2021","unstructured":"Al Wattar BH, Fisher M, Bevington L, Talaulikar V, Davies M, Conway G, Yasmin E (2021) Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J Clin Endocrinol Metab 106(8):2436\u20132446. https:\/\/doi.org\/10.1210\/clinem\/dgab232","journal-title":"J Clin Endocrinol Metab"},{"key":"2117_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-00919-5","author":"HH Almalki","year":"2020","unstructured":"Almalki HH, Alshibani TM, Alhifany AA, Almohammed OA (2020) Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. BMC Womens Health. https:\/\/doi.org\/10.1186\/s12905-020-00919-5","journal-title":"BMC Womens Health"},{"key":"2117_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMSU.2021.103123","volume":"72","author":"E Alshdaifat","year":"2021","unstructured":"Alshdaifat E, Sindiani A, Amarin Z, Absy N, AlOsta N, Abuhayyeh HA, Alwani M (2021) Awareness of polycystic ovary syndrome: a university students\u2019 perspective. Ann Med Surg (Lond) 72:103123. https:\/\/doi.org\/10.1016\/J.AMSU.2021.103123","journal-title":"Ann Med Surg (Lond)"},{"issue":"3","key":"2117_CR11","doi-asserted-by":"publisher","first-page":"280.e1","DOI":"10.1016\/j.ajog.2020.08.048","volume":"224","author":"S Alur-Gupta","year":"2021","unstructured":"Alur-Gupta S, Boland MR, Barnhart KT, Sammel MD, Dokras A (2021) Postpartum complications increased in women with polycystic ovary syndrome. Am J Obstet Gynecol 224(3):280.e1-280.e13. https:\/\/doi.org\/10.1016\/j.ajog.2020.08.048","journal-title":"Am J Obstet Gynecol"},{"key":"2117_CR213","unstructured":"Amiri M, Golsorkhtabaramiri M, Esmaeilzadeh S, Ghofrani F, Bijani A, Ghorbani L, Delavar MA (2014) Effect of metformin and flutamide on anthropometric indices and laboratory tests in obese\/overweight PCOS women under hypocaloric diet. In J Reprod Infertil, vol 15, no. 4."},{"issue":"11","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.18502\/ijrm.v20i11.12357","volume":"20","author":"M Amiri","year":"2022","unstructured":"Amiri M, Bidhendi-Yarandi R, Fallahzadeh A, Marzban Z, Tehrani FR, Research and Clinical Center for Infertitlity (2022) Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int J Reproductive BioMed (IJRM) 20(11):893\u2013914. https:\/\/doi.org\/10.18502\/ijrm.v20i11.12357","journal-title":"Int J Reproductive BioMed (IJRM)"},{"key":"2117_CR13","first-page":"19","volume":"6","author":"I Ara","year":"2022","unstructured":"Ara I, Maqbool M, Gani I, Kashmir O, Kashmir I (2022) The story of polycystic ovary syndrome: A challenging condition with numerous consequences for women of childbearing age. Int J Cyrrent Res Physiol Pharmacol 6:19\u201331","journal-title":"Int J Cyrrent Res Physiol Pharmacol"},{"key":"2117_CR207","doi-asserted-by":"publisher","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C (2022) Controversies in the pathogenesis, diagnosis and treatment of pcos: focus on insulin resistance, inflammation, and hyperandrogenism. In: International journal of molecular sciences, vol 23, no. 8. MDPI. https:\/\/doi.org\/10.3390\/ijms23084110","DOI":"10.3390\/ijms23084110"},{"issue":"9","key":"2117_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/09513590.2021.1943344","volume":"37","author":"E Asanidze","year":"2021","unstructured":"Asanidze E, Kristesashvili J, Parunashvili N, Karelishvili N, Etsadashvili N (2021) Challenges in diagnosis of polycystic ovary syndrome in adolescence. Gynecol Endocrinol 37(9):819\u2013822. https:\/\/doi.org\/10.1080\/09513590.2021.1943344","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2117_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.18502\/ijrm.v20i1.10404","volume":"20","author":"F Azin","year":"2022","unstructured":"Azin F, Khazali H, Research and Clinical Center for Infertitlity (2022) Phytotherapy of polycystic ovary syndrome: a review. Int J Reprod Biomed 20(1):13\u201320. https:\/\/doi.org\/10.18502\/ijrm.v20i1.10404","journal-title":"Int J Reprod Biomed"},{"issue":"2","key":"2117_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0954422418000136","volume":"31","author":"L Barrea","year":"2018","unstructured":"Barrea L, Marzullo P, Muscogiuri G, Di Somma C, Scacchi M, Orio F, Aimaretti G, Colao A, Savastano S (2018) Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev 31(2):291\u2013301. https:\/\/doi.org\/10.1017\/S0954422418000136","journal-title":"Nutr Res Rev"},{"key":"2117_CR18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae518","author":"TR Berni","year":"2024","unstructured":"Berni TR, Morgan CL, Rees DA (2024) Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgae518","journal-title":"J Clin Endocrinol Metab"},{"key":"2117_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32351","author":"MD Bharali","year":"2022","unstructured":"Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V (2022) Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. https:\/\/doi.org\/10.7759\/cureus.32351","journal-title":"Cureus"},{"key":"2117_CR21","doi-asserted-by":"publisher","first-page":"215013192412494","DOI":"10.1177\/21501319241249405","volume":"15","author":"M Bornstein","year":"2024","unstructured":"Bornstein M, Church AC, Masterson K, Norris AH (2024) Perceptions and experiences with healthcare providers among people navigating reproductive and fertility decisions. J Primary Care Commun Health 15:21501319241249404. https:\/\/doi.org\/10.1177\/21501319241249405","journal-title":"J Primary Care Commun Health"},{"issue":"6","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/01443615.2020.1803244","volume":"41","author":"M Bozkurt","year":"2021","unstructured":"Bozkurt M, Kara Bozkurt D, Kurban D, Takmaz T, Sevket O, Ozcan P (2021) 2-D and 3-D ultrasonographic characteristics of the ovary in women with PCOS and multifollicular ovaries. J Obstet Gynaecol 41(6):920\u2013926. https:\/\/doi.org\/10.1080\/01443615.2020.1803244","journal-title":"J Obstet Gynaecol"},{"key":"2117_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2024.1475132","author":"A Bushell","year":"2024","unstructured":"Bushell A, Crespi BJ, Frontiers Media SA (2024) The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence. Front Reprod Health. https:\/\/doi.org\/10.3389\/frph.2024.1475132","journal-title":"Front Reprod Health"},{"key":"2117_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736320","author":"WY Cai","year":"2022","unstructured":"Cai WY, Luo X, Song J, Ji D, Zhu J, Duan C, Wu W, Wu XK, Xu J (2022) Effect of hyperinsulinemia and insulin resistance on endocrine, metabolic, and reproductive outcomes in non-PCOS women undergoing assisted reproduction: a retrospective cohort study. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2021.736320","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4274\/jtgga.galenos.2021.2021.0077","volume":"22","author":"\u00d6 \u00c7elik","year":"2021","unstructured":"\u00c7elik \u00d6, K\u00f6se MF, Galenos Publishing House (2021) An overview of polycystic ovary syndrome in aging women. J Turkish-German Gynecol Associat 22(4):326\u2013333. https:\/\/doi.org\/10.4274\/jtgga.galenos.2021.2021.0077","journal-title":"J Turkish-German Gynecol Associat"},{"issue":"2","key":"2117_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1573404818666220208110240","volume":"19","author":"V Chaturvedi","year":"2022","unstructured":"Chaturvedi V, Sharma D, Pandey V, Mishra S, Shrivastava SP, Sharma A, Malviya R (2022) Polycystic ovarian syndrome: current situation of female hormonal disorder. Curr Women Health Rev 19(2):17\u201325. https:\/\/doi.org\/10.2174\/1573404818666220208110240","journal-title":"Curr Women Health Rev"},{"key":"2117_CR28","doi-asserted-by":"publisher","first-page":"731569","DOI":"10.3389\/fendo.2021.731569","volume":"12","author":"H Chen","year":"2021","unstructured":"Chen H, Zhang Y, Li S, Tao Y, Gao R, Xu W, Yang Y, Cheng K, Wang Y, Qin L (2021) The association between genetically predicted systemic inflammatory regulators and polycystic ovary syndrome: a mendelian randomization study. Front Endocrinol 12:731569. https:\/\/doi.org\/10.3389\/fendo.2021.731569","journal-title":"Front Endocrinol"},{"issue":"1","key":"2117_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13668-023-00451-6","volume":"12","author":"ME \u00c7\u0131tar Daz\u0131ro\u011flu","year":"2023","unstructured":"\u00c7\u0131tar Daz\u0131ro\u011flu ME, Acar Tek N (2023) The effect on inflammation of adherence to the Mediterranean diet in polycystic ovary syndrome. Curr Nutr Rep 12(1):191\u2013202. https:\/\/doi.org\/10.1007\/s13668-023-00451-6","journal-title":"Curr Nutr Rep"},{"issue":"9","key":"2117_CR30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70501","volume":"16","author":"L Cochran","year":"2024","unstructured":"Cochran L, Nadolny R, Garcia K, Kluglein KA, Yagoda A, Gandhi P, Dressel J, Prol B, Peralta R, Shipp A, Costin JM (2024) Available treatments and adjunctive therapies for polycystic ovarian syndrome (PCOS) patients of reproductive age: a scoping review. Cureus 16(9):e70501. https:\/\/doi.org\/10.7759\/cureus.70501","journal-title":"Cureus"},{"issue":"10","key":"2117_CR31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/09513590.2021.1958310","volume":"37","author":"J Coll\u00e9e","year":"2021","unstructured":"Coll\u00e9e J, Mawet M, Tebache L, Nisolle M, Brichant G (2021) Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecol Endocrinol 37(10):869\u2013874. https:\/\/doi.org\/10.1080\/09513590.2021.1958310","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2117_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/17446651.2023.2256405","volume":"18","author":"MJ Concepci\u00f3n-Zavaleta","year":"2023","unstructured":"Concepci\u00f3n-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, Durand-V\u00e1squez MdelC, Ildefonso-Najarro SP, Rafael-Robles LdelP, Concepci\u00f3n-Urteaga LA, Gamarra-Osorio ER, Su\u00e1rez-Rojas J, Paz-Ibarra J (2023) Endocrine factors associated with infertility in women: an updated review. Expert Rev Endocrinol Metab 18(5):399\u2013417. https:\/\/doi.org\/10.1080\/17446651.2023.2256405","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2117_CR206","doi-asserted-by":"publisher","unstructured":"Costello M, Garad R, Hart R, Homer H, Johnson L, Jordan C, Mocanu E, Qiao J, Rombauts L, Teede HJ, Vanky E, Venetis C, Ledger W (2019) A Review of first line infertility treatments and supporting evidence in women with polycystic ovary syndrome. In: Medical sciences (Basel, Switzerland), vol 7, no. 9. NLM (Medline). https:\/\/doi.org\/10.3390\/medsci7090095","DOI":"10.3390\/medsci7090095"},{"key":"2117_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01208-y","author":"S Cowan","year":"2023","unstructured":"Cowan S, Lim S, Alycia C, Pirotta S, Thomson R, Gibson-Helm M, Blackmore R, Naderpoor N, Bennett C, Ee C, Rao V, Mousa A, Alesi S, Moran L (2023) Lifestyle management in polycystic ovary syndrome \u2013 beyond diet and physical activity. BMC Endocr Disord. https:\/\/doi.org\/10.1186\/s12902-022-01208-y","journal-title":"BMC Endocr Disord"},{"issue":"7","key":"2117_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/ENDOCR\/BQAA061","volume":"161","author":"MJ Cox","year":"2020","unstructured":"Cox MJ, Edwards MC, Paris VR, Aflatounian A, Ledger WL, Gilchrist RB, Padmanabhan V, Handelsman DJ, Walters KA (2020) Androgen action in adipose tissue and the brain are key mediators in the development of PCOS traits in a mouse model. Endocrinology 161(7):1\u201315. https:\/\/doi.org\/10.1210\/ENDOCR\/BQAA061","journal-title":"Endocrinology"},{"issue":"4","key":"2117_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS (2020) The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 13(4):261\u2013271. https:\/\/doi.org\/10.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"key":"2117_CR36","doi-asserted-by":"publisher","first-page":"1364703","DOI":"10.3389\/fmed.2024.1364703","volume":"11","author":"D DiEuliis","year":"2024","unstructured":"DiEuliis D, Giordano JJ (2024) Safely balancing a double-edged blade: identifying and mitigating emerging biosecurity risks in precision medicine. Front Med 11:1364703. https:\/\/doi.org\/10.3389\/fmed.2024.1364703","journal-title":"Front Med"},{"key":"2117_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q (2021) Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol Lausanne. https:\/\/doi.org\/10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol Lausanne"},{"issue":"3","key":"2117_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3934\/publichealth.2020041","volume":"7","author":"J Djedjibegovic","year":"2020","unstructured":"Djedjibegovic J, Marjanovic A, Kobilica I, Turalic A, Lugusic A, Sober M (2020) Lifestyle management of polycystic ovary syndrome: a single-center study in Bosnia and Herzegovina. AIMS Public Health 7(3):504\u2013520. https:\/\/doi.org\/10.3934\/publichealth.2020041","journal-title":"AIMS Public Health"},{"issue":"12","key":"2117_CR39","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1210\/jc.2013-2374","volume":"98","author":"JP Domecq","year":"2013","unstructured":"Domecq JP, Prutsky G, Mullan RJ, Sundaresh V, Wang AT, Erwin PJ, Welt C, Ehrmann D, Montori VM, Murad MH (2013) Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab 98(12):4646\u20134654. https:\/\/doi.org\/10.1210\/jc.2013-2374","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2117_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0043-1776419","volume":"41","author":"C Ee","year":"2023","unstructured":"Ee C (2023) The role of the primary care physician in the assessment and management of polycystic ovary syndrome. Semin Reprod Med 41(1\u20132):20\u201325. https:\/\/doi.org\/10.1055\/s-0043-1776419","journal-title":"Semin Reprod Med"},{"key":"2117_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00890-8","author":"C Ee","year":"2021","unstructured":"Ee C, Pirotta S, Mousa A, Moran L, Lim S (2021) Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success. BMC Endocr Disord. https:\/\/doi.org\/10.1186\/s12902-021-00890-8","journal-title":"BMC Endocr Disord"},{"key":"2117_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082278","author":"ME Espinosa","year":"2024","unstructured":"Espinosa ME, Melo A, Leon M, Bautista-Valarezo E, Zambrano F, Uribe P, Bravo A, Taubert A, Hermosilla C, Iturrieta V, S\u00e1nchez R (2024) Vaginal microbiota and proinflammatory status in patients with polycystic ovary syndrome: an exploratory study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13082278","journal-title":"J Clin Med"},{"issue":"6","key":"2117_CR43","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/J.FERTNSTERT.2020.12.015","volume":"115","author":"U Ezeh","year":"2021","unstructured":"Ezeh U, Ezeh C, Pisarska MD, Azziz R (2021) Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism. Fertil Steril 115(6):1557\u20131568. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2020.12.015","journal-title":"Fertil Steril"},{"key":"2117_CR220","doi-asserted-by":"publisher","unstructured":"Forslund M, Melin J, Alesi S, Piltonen T, Romualdi D, Tay CT, Witchel S, Pena A, Mousa A, Teede H (2023) Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol 99(1):79\u201391. https:\/\/doi.org\/10.1111\/cen.14913","DOI":"10.1111\/cen.14913"},{"issue":"1","key":"2117_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/aogs.14725","volume":"103","author":"M Forslund","year":"2024","unstructured":"Forslund M, Melin J, Stener-Victorin E, Hirschberg AL, Teede H, Vanky E, Piltonen T (2024) International evidence-based guideline on assessment and management of PCOS\u2014a Nordic perspective. Acta Obstet Gynecol Scand 103(1):7\u201312. https:\/\/doi.org\/10.1111\/aogs.14725","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2117_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/humrep\/dead231","volume":"39","author":"S Gameiro","year":"2024","unstructured":"Gameiro S, Adcock E, Munoz CG, O\u2019Hanrahan M, D\u2019Angelo A, Boivin J (2024) What is bad news in fertility care? A qualitative\u00e3nalysis of staff\u00e3nd patients\u2019\u00e3ccounts of bad\u00e3nd challenging news in fertility care. Hum Reprod 39(1):139\u2013146. https:\/\/doi.org\/10.1093\/humrep\/dead231","journal-title":"Hum Reprod"},{"issue":"2","key":"2117_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ijgo.13125","volume":"149","author":"MA Ganie","year":"2020","unstructured":"Ganie MA, Rashid A, Sahu D, Nisar S, Wani IA, Khan J (2020) Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: a cross-sectional study. Int J Gynaecol Obstet 149(2):231\u2013236. https:\/\/doi.org\/10.1002\/ijgo.13125","journal-title":"Int J Gynaecol Obstet"},{"key":"2117_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/J.COEMR.2020.04.007","volume":"12","author":"RM Garad","year":"2020","unstructured":"Garad RM, Teede HJ (2020) Polycystic ovary syndrome: improving policies, awareness, and clinical care. Curr Opin Endocr Metab Res 12:112\u2013118. https:\/\/doi.org\/10.1016\/J.COEMR.2020.04.007","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"1","key":"2117_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.17925\/EE.2023.19.1.71","volume":"19","author":"AD Genazzani","year":"2023","unstructured":"Genazzani AD, Genazzani AR (2023) Polycystic ovary syndrome as metabolic disease: new insights on insulin resistance. Eur Endocrinol 19(1):71\u201377. https:\/\/doi.org\/10.17925\/EE.2023.19.1.71","journal-title":"Eur Endocrinol"},{"issue":"2","key":"2117_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/endocrines3020024","volume":"3","author":"AD Genazzani","year":"2022","unstructured":"Genazzani AD, Battipaglia C, Semprini E, Arnesano M, Ambrosetti F, Sponzilli A, Tomatis V, Petrillo T (2022) Familial diabetes in obese PCOS predisposes individuals to compensatory hyperinsulinemia and insulin resistance (IR) also for reduced hepatic insulin extraction (HIE). Endocrines 3(2):296\u2013302. https:\/\/doi.org\/10.3390\/endocrines3020024","journal-title":"Endocrines"},{"key":"2117_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01236-9","author":"Y Geng","year":"2023","unstructured":"Geng Y, Liu Z, Hu R, Ma W, Wu X, Dong H, Song K, Xu X, Huang Y, Li F, Song Y, Zhang M (2023) Opportunities and challenges: interleukin-22 comprehensively regulates polycystic ovary syndrome from metabolic and immune aspects. J Ovarian Res. https:\/\/doi.org\/10.1186\/s13048-023-01236-9","journal-title":"J Ovarian Res"},{"issue":"4","key":"2117_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22042048","volume":"22","author":"P Giampaolino","year":"2021","unstructured":"Giampaolino P, Foreste V, Di Filippo C, Gallo A, Mercorio A, Serafino P, Improda FP, Verrazzo P, Zara G, Buonfantino C, Borgo M, Riemma G, De Angelis C, Zizolfi B, Bifulco G, Corte LD (2021) Microbiome and PCOS: state-of-art and future aspects. Int J Mol Sci 22(4):1\u201316. https:\/\/doi.org\/10.3390\/ijms22042048","journal-title":"Int J Mol Sci"},{"issue":"50","key":"2117_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036075","volume":"102","author":"H Guo","year":"2023","unstructured":"Guo H, Luo J, Lin H (2023) Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: a review. Medicine (Baltimore) 102(50):E36075. https:\/\/doi.org\/10.1097\/MD.0000000000036075","journal-title":"Medicine (Baltimore)"},{"key":"2117_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03097-1","author":"P Hager","year":"2024","unstructured":"Hager P, Jungmann F, Holland R, Bhagat K, Hubrecht I, Knauer M, Vielhauer J, Makowski M, Braren R, Kaissis G, Rueckert D (2024) Evaluation and mitigation of the limitations of large language models in clinical decision-making. Nat Med. https:\/\/doi.org\/10.1038\/s41591-024-03097-1","journal-title":"Nat Med"},{"key":"2117_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02868-1","author":"Z Hariri","year":"2024","unstructured":"Hariri Z, Yari Z, Hoseini S, Abhari K, Sohrab G (2024) Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial. BMC Womens Health. https:\/\/doi.org\/10.1186\/s12905-023-02868-1","journal-title":"BMC Womens Health"},{"issue":"4","key":"2117_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/J.RBMO.2024.104293","volume":"49","author":"C Harrison","year":"2024","unstructured":"Harrison C, Tay CT, Busby MA, Mousa A, Teede H, Boivin J (2024) Challenges experienced by those with polycystic ovary syndrome in healthcare interactions: a qualitative evidence synthesis. Reprod Biomed Online 49(4):104293. https:\/\/doi.org\/10.1016\/J.RBMO.2024.104293","journal-title":"Reprod Biomed Online"},{"key":"2117_CR204","doi-asserted-by":"publisher","unstructured":"Heidarpour M, Mojarad M, Mazaheri-Tehrani S, Kachuei A, Najimi A, Shafie D, Rezvanian H (2024) Comparative effectiveness of antidiabetic drugs as an additional therapy to metformin in women with polycystic ovary syndrome: a systematic review of metabolic approaches. In: International journal of endocrinology, vol 2024. Hindawi Limited. https:\/\/doi.org\/10.1155\/2024\/9900213","DOI":"10.1155\/2024\/9900213"},{"issue":"5","key":"2117_CR56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1210\/clinem\/dgac673","volume":"108","author":"AL Hirschberg","year":"2023","unstructured":"Hirschberg AL (2023) Approach to investigation of hyperandrogenism in a postmenopausal woman. J Clin Endocrinol Metab 108(5):1243\u20131253. https:\/\/doi.org\/10.1210\/clinem\/dgac673","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2117_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M23-2240","volume":"177","author":"TW Hsu","year":"2024","unstructured":"Hsu TW, Kao YC, Tsai SJ, Bai YM, Su TP, Chen TJ, Liang CS, Chen MH (2024) Suicide attempts after a diagnosis of polycystic ovary syndrome a cohort study. Ann Intern Med 177(3):335\u2013342. https:\/\/doi.org\/10.7326\/M23-2240","journal-title":"Ann Intern Med"},{"key":"2117_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5536849","author":"J Hu","year":"2021","unstructured":"Hu J, Shi W, Xu J, Liu S, Hu S, Fu W, Wang J, Han F (2021) Complementary and alternative medicine for the treatment of abnormal endometrial conditions in women with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2021\/5536849","journal-title":"Evid Based Complement Alternat Med"},{"key":"2117_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6237141","author":"RO Ibrahim","year":"2020","unstructured":"Ibrahim RO, Omer SH, Fattah CN (2020) The correlation between hormonal disturbance in PCOS women and serum level of Kisspeptin. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2020\/6237141","journal-title":"Int J Endocrinol"},{"issue":"8","key":"2117_CR60","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5603\/gpl.98849","volume":"95","author":"KM Jakubowska-Kowal","year":"2024","unstructured":"Jakubowska-Kowal KM, Skrzynska KJ, Gawlik-Starzyk AM (2024) Prevalence and diagnosis of polycystic ovary syndrome (PCOS) in adolescents \u2014 what\u2019s new in 2023? Systematic review. Ginekol Pol 95(8):643\u2013649. https:\/\/doi.org\/10.5603\/gpl.98849","journal-title":"Ginekol Pol"},{"key":"2117_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5555315","author":"LY Jia","year":"2021","unstructured":"Jia LY, Feng JX, Li JL, Liu FY, Xie LZ, Luo SJ, Han FJ (2021) The complementary and alternative medicine for polycystic ovary syndrome: a review of clinical application and mechanism. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2021\/5555315","journal-title":"Evid Based Complement Alternat Med"},{"issue":"9","key":"2117_CR62","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s43032-021-00629-9","volume":"29","author":"NX Jiang","year":"2022","unstructured":"Jiang NX, Li XL (2022) The disorders of endometrial receptivity in PCOS and its mechanisms. Reprod Sci 29(9):2465\u20132476. https:\/\/doi.org\/10.1007\/s43032-021-00629-9","journal-title":"Reprod Sci"},{"key":"2117_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233876","author":"G Jiskoot","year":"2020","unstructured":"Jiskoot G, de Dietz Loos A, Beerthuizen A, Timman R, Busschbach J, Laven J (2020) Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): a secondary analysis of a randomized controlled trial. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0233876","journal-title":"PLoS ONE"},{"key":"2117_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s40337-022-00593-y","author":"G Jiskoot","year":"2022","unstructured":"Jiskoot G, de Loos AD, Timman R, Beerthuizen A, Laven J, Busschbach J (2022a) Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial. J Eat Disord. https:\/\/doi.org\/10.1186\/s40337-022-00593-y","journal-title":"J Eat Disord"},{"issue":"3","key":"2117_CR65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/J.RBMO.2022.05.001","volume":"45","author":"G Jiskoot","year":"2022","unstructured":"Jiskoot G, van der Kooi AL, Busschbach J, Laven J, Beerthuizen A (2022b) Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis. Reprod Biomed Online 45(3):599\u2013607. https:\/\/doi.org\/10.1016\/J.RBMO.2022.05.001","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"2117_CR66","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.14757","volume":"97","author":"AE Joham","year":"2022","unstructured":"Joham AE, Piltonen T, Lujan ME, Kiconco S, Tay CT (2022) Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome. Clin Endocrinol 97(2):165\u2013173. https:\/\/doi.org\/10.1111\/cen.14757","journal-title":"Clin Endocrinol"},{"key":"2117_CR67","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2023.13754","author":"JE Johnson","year":"2023","unstructured":"Johnson JE, Daley D, Tarta C, Stanciu PI (2023) Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta-analysis. Oncol Lett. https:\/\/doi.org\/10.3892\/ol.2023.13754","journal-title":"Oncol Lett"},{"key":"2117_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20889","author":"W Jung","year":"2023","unstructured":"Jung W, Choi H, Kim J, Kim J, Kim W, Nurkolis F, Kim B (2023) Effects of natural products on polycystic ovary syndrome: from traditional medicine to modern drug discovery. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20889","journal-title":"Heliyon"},{"issue":"9","key":"2117_CR70","doi-asserted-by":"publisher","first-page":"E3400","DOI":"10.1210\/clinem\/dgaa426","volume":"105","author":"M Kazemi","year":"2020","unstructured":"Kazemi M, Jarrett BY, Parry SA, Thalacker-Mercer AE, Hoeger KM, Spandorfer SD, Lujan ME (2020) Osteosarcopenia in reproductive-aged women with polycystic ovary syndrome: a multicenter case-control study. J Clin Endocrinol Metab 105(9):E3400\u2013E3414. https:\/\/doi.org\/10.1210\/clinem\/dgaa426","journal-title":"J Clin Endocrinol Metab"},{"key":"2117_CR71","doi-asserted-by":"publisher","DOI":"10.1177\/2042018820934319","author":"P Kempegowda","year":"2020","unstructured":"Kempegowda P, Melson E, Manolopoulos KN, Arlt W, O\u2019Reilly MW (2020) Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome. Ther Adv Endocrinol Metab. https:\/\/doi.org\/10.1177\/2042018820934319","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2117_CR72","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3889\/oamjms.2020.4569","volume":"8","author":"M Khmil","year":"2020","unstructured":"Khmil M, Khmil S, Marushchak M (2020) Hormone imbalance in women with infertility caused by polycystic ovary syndrome: is there a connection with body mass index? Open Access Maced J Med Sci 8:731\u2013737. https:\/\/doi.org\/10.3889\/oamjms.2020.4569","journal-title":"Open Access Maced J Med Sci"},{"key":"2117_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11111953","author":"S Kiconco","year":"2021","unstructured":"Kiconco S, Mousa A, Azziz R, Enticott J, Suturina LV, Zhao X, Gambineri A, Tehrani FR, Yildiz BO, Kim JJ, Teede HJ, Joham AE (2021) Pcos phenotype in unselected populations study (P-pup): protocol for a systematic review and defining pcos diagnostic features with pooled individual participant data. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics11111953","journal-title":"Diagnostics"},{"issue":"8","key":"2117_CR74","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/jdv.18842","volume":"37","author":"EJ Klein","year":"2023","unstructured":"Klein EJ, Oh CS, Karim M, Shapiro J, Lo Sicco K (2023) A practical approach to the management of hair loss in patients with polycystic ovary syndrome. J Eur Acad Dermatol Venereol 37(8):1480\u20131489. https:\/\/doi.org\/10.1111\/jdv.18842","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2117_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1482054","author":"M Kleinov\u00e1","year":"2024","unstructured":"Kleinov\u00e1 M, Varga I, \u010ceh\u00e1kov\u00e1 M, Valent M, Klein M (2024) Exploring the black box of human reproduction: endometrial organoids and assembloids - generation, implantation modeling, and future clinical perspectives. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2024.1482054","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"2117_CR76","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s13679-020-00388-9","volume":"9","author":"E Kostopoulou","year":"2020","unstructured":"Kostopoulou E, Anagnostis P, Bosdou JK, Spiliotis BE, Goulis DG (2020) Polycystic ovary syndrome in adolescents: pitfalls in diagnosis and management. Curr Obes Rep 9(3):193\u2013203. https:\/\/doi.org\/10.1007\/s13679-020-00388-9","journal-title":"Curr Obes Rep"},{"issue":"10","key":"2117_CR77","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1080\/15548627.2021.1938914","volume":"17","author":"S Kumariya","year":"2021","unstructured":"Kumariya S, Ubba V, Jha RK, Gayen JR (2021) Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective. Autophagy 17(10):2706\u20132733. https:\/\/doi.org\/10.1080\/15548627.2021.1938914","journal-title":"Autophagy"},{"key":"2117_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/J.OBMED.2024.100543","volume":"48","author":"SU Lad","year":"2024","unstructured":"Lad SU, Sunil Vyas G, Mohd S, Mishra V, Wadhwa S, Singh S, Harish V (2024) Recent advances in therapeutic interventions of polycystic ovarian syndrome. Obes Med 48:100543. https:\/\/doi.org\/10.1016\/J.OBMED.2024.100543","journal-title":"Obes Med"},{"key":"2117_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biotech12010004","author":"JN Lakshmi","year":"2023","unstructured":"Lakshmi JN, Babu AN, Kiran SSM, Nori LP, Hassan N, Ashames A, Bhandare RR, Shaik AB (2023) Herbs as a source for the treatment of polycystic ovarian syndrome: a systematic review. Biotech. https:\/\/doi.org\/10.3390\/biotech12010004","journal-title":"Biotech"},{"issue":"1","key":"2117_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0000000000000563","volume":"64","author":"JA Lentscher","year":"2021","unstructured":"Lentscher JA, Decherney AH (2021) Clinical presentation and diagnosis of polycystic ovarian syndrome. Clin Obstet Gynecol 64(1):3\u201311. https:\/\/doi.org\/10.1097\/GRF.0000000000000563","journal-title":"Clin Obstet Gynecol"},{"key":"2117_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02817-2","author":"C Li","year":"2021","unstructured":"Li C, Xing C, Zhang J, Zhao H, Shi W, He B (2021) Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-021-02817-2","journal-title":"J Transl Med"},{"key":"2117_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01073-0","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H (2022) Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. https:\/\/doi.org\/10.1038\/s41392-022-01073-0","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"2117_CR83","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4239\/wjd.v13.i3.240","volume":"13","author":"W-T Liao","year":"2022","unstructured":"Liao W-T, Huang J-Y, Lee M-T, Yang Y-C, Wu C-C (2022) Higher risk of type 2 diabetes in young women with polycystic ovary syndrome: a 10-year retrospective cohort study. World J Diabetes 13(3):240\u2013250. https:\/\/doi.org\/10.4239\/wjd.v13.i3.240","journal-title":"World J Diabetes"},{"issue":"6","key":"2117_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/J.JOGOH.2020.101894","volume":"50","author":"S Lie Fong","year":"2021","unstructured":"Lie Fong S, Douma A, Verhaeghe J (2021) Implementing the international evidence-based guideline of assessment and management of polycystic ovary syndrome (PCOS): how to achieve weight loss in overweight and obese women with PCOS? J Gynecol Obstet Hum Reprod 50(6):101894. https:\/\/doi.org\/10.1016\/J.JOGOH.2020.101894","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2117_CR85","doi-asserted-by":"publisher","first-page":"709674","DOI":"10.3389\/fpsyt.2021.709674","volume":"12","author":"H Lin","year":"2021","unstructured":"Lin H, Liu M, Zhong D, Ng EHY, Liu J, Li J, Shi Y, Zhang C, Wen X, Mai Z, Ou M, Ma H (2021) The prevalence and factors associated with anxiety-like and depression-like behaviors in women with polycystic ovary syndrome. Front Psychiatry 12:709674. https:\/\/doi.org\/10.3389\/fpsyt.2021.709674","journal-title":"Front Psychiatry"},{"issue":"6","key":"2117_CR86","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/humrep\/der096","volume":"26","author":"\u00c5 Lindholm","year":"2011","unstructured":"Lindholm \u00c5, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundstr\u00f6m Poromaa I, Bur\u00e9n J (2011) No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod 26(6):1478\u20131485. https:\/\/doi.org\/10.1093\/humrep\/der096","journal-title":"Hum Reprod"},{"issue":"4","key":"2117_CR87","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/humrep\/deaa371","volume":"36","author":"J Liu","year":"2021","unstructured":"Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, Han L (2021) Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global burden of disease study 2017. Hum Reprod 36(4):1108\u20131119. https:\/\/doi.org\/10.1093\/humrep\/deaa371","journal-title":"Hum Reprod"},{"issue":"4","key":"2117_CR88","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/01443615.2021.1931066","volume":"42","author":"Q Liu","year":"2022","unstructured":"Liu Q, Wang J, Xu Q, Kong L, Wang J (2022a) A retrospective cohort study of obstetric complications and birth outcomes in women with polycystic ovarian syndrome\u202f: Obstetric complications and birth outcomes in women with PCOS. J Obstet Gynaecol 42(4):574\u2013579. https:\/\/doi.org\/10.1080\/01443615.2021.1931066","journal-title":"J Obstet Gynaecol"},{"key":"2117_CR89","doi-asserted-by":"publisher","first-page":"787876","DOI":"10.3389\/fendo.2022.787876","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Z, Wang Y, Cai Q, Liu H, Xu C, Zhang F (2022b) IL-15 participates in the pathogenesis of polycystic ovary syndrome by affecting the activity of granulosa cells. Front Endocrinol 13:787876. https:\/\/doi.org\/10.3389\/fendo.2022.787876","journal-title":"Front Endocrinol"},{"issue":"1","key":"2117_CR90","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/humrep\/dead241","volume":"39","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang J, Wang S (2024) Global, regional,\u00e3nd national burden of infertility\u00e3ttributable to PCOS, 1990\u20132019. Hum Reprod 39(1):108\u2013118. https:\/\/doi.org\/10.1093\/humrep\/dead241","journal-title":"Hum Reprod"},{"key":"2117_CR211","doi-asserted-by":"publisher","unstructured":"Long T, Zhang Y, Zeng C, Zheng S, Zhou L, Liu H (2022) Effects of low-dose spironolactone combined with metformin or either drug alone on insulin resistance in patients with polycystic ovary syndrome: a pilot study. Int J Endocrinol 2022. https:\/\/doi.org\/10.1155\/2022\/9927240","DOI":"10.1155\/2022\/9927240"},{"key":"2117_CR91","doi-asserted-by":"publisher","DOI":"10.1177\/2633494120911038","volume":"14","author":"YV Louwers","year":"2020","unstructured":"Louwers YV, Laven JSE (2020) Characteristics of polycystic ovary syndrome throughout life. Ther Adv Reprod Health 14:263349412091103. https:\/\/doi.org\/10.1177\/2633494120911038","journal-title":"Ther Adv Reprod Health"},{"issue":"17\u201318","key":"2117_CR92","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1111\/jocn.16701","volume":"32","author":"E Lumley","year":"2023","unstructured":"Lumley E, O\u2019Cathain A, Drabble S, Pye C, Brian K, Metwally M (2023) Managing ovarian hyperstimulation syndrome: a qualitative interview study with women and healthcare professionals. J Clin Nurs 32(17\u201318):6599\u20136610. https:\/\/doi.org\/10.1111\/jocn.16701","journal-title":"J Clin Nurs"},{"key":"2117_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ph18050680","author":"P Maan","year":"2025","unstructured":"Maan P, Gautam R, Vasudevan S, Menon GR, Arora A, Nair A, Jabbar PK, Arora T (2025) Pharmacological and non-pharmacological interventions for polycystic ovary syndrome (PCOS) in Indian women: a systematic review and meta-analysis. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph18050680","journal-title":"Pharmaceuticals"},{"key":"2117_CR94","doi-asserted-by":"publisher","first-page":"1294406","DOI":"10.3389\/fendo.2023.1294406","volume":"14","author":"S Malik","year":"2023","unstructured":"Malik S, Saeed S, Saleem A, Khan MI, Khan A, Akhtar MF (2023) Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs. Front Endocrinol 14:1294406. https:\/\/doi.org\/10.3389\/fendo.2023.1294406","journal-title":"Front Endocrinol"},{"key":"2117_CR95","doi-asserted-by":"publisher","first-page":"286","DOI":"10.26444\/jpccr\/192128","volume":"18","author":"B Maliszewska","year":"2024","unstructured":"Maliszewska B, Tokarzewska A, \u0141asica M, Ma\u0142yszek M, \u0141aba \u0141, Dziurda S, \u0141om\u017ca-\u0141aba AW, \u0141uczy\u0144ski D (2024) Psychiatric disorders in women with polycystic ovary syndrome. J Pre-Clin Clin Res 18:286\u2013292. https:\/\/doi.org\/10.26444\/jpccr\/192128","journal-title":"J Pre-Clin Clin Res"},{"issue":"1","key":"2117_CR96","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5935\/1518-0557.20220024","volume":"27","author":"A Manouchehri","year":"2023","unstructured":"Manouchehri A, Abbaszadeh S, Ahmadi M, Nejad FK, Bahmani M, Dastyar N, SBRA\u2014Associa\u00e7\u00e3o Brasileira de Reprodu\u00e7\u00e3o Assistida (Brazilian Society of Assisted Reproduction) (2023) Polycystic ovaries and herbal remedies: a systematic review. J Bras Reprod Assist 27(1):85\u201391. https:\/\/doi.org\/10.5935\/1518-0557.20220024","journal-title":"J Bras Reprod Assist"},{"key":"2117_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01224-y","author":"A Mansour","year":"2022","unstructured":"Mansour A, Hashemi Taheri AP, Moradi B, Mohajeri-Tehrani MR, Qorbani M, Ghorbani Pashakolaee S, Sanginabadi M, Sajjadi-Jazi SM (2022) Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome. BMC Endocr Disord. https:\/\/doi.org\/10.1186\/s12902-022-01224-y","journal-title":"BMC Endocr Disord"},{"key":"2117_CR98","doi-asserted-by":"publisher","unstructured":"March C, Witchel S (2021) Acne, hirsutism, and other signs of increased androgens. In: Endocrine Conditions in Pediatrics, pp. 85\u201394. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-52215-5_14","DOI":"10.1007\/978-3-030-52215-5_14"},{"issue":"9","key":"2117_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9092700","volume":"9","author":"D Mayrhofer","year":"2020","unstructured":"Mayrhofer D, Hager M, Walch K, Ghobrial S, Rogenhofer N, Marculescu R, Seemann R, Ott J (2020) The prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: a retrospective cohort study and meta-analysis. J Clin Med 9(9):1\u201315. https:\/\/doi.org\/10.3390\/jcm9092700","journal-title":"J Clin Med"},{"issue":"12","key":"2117_CR100","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.18502\/ijrm.v18i12.8026","volume":"18","author":"S Mehrabadi","year":"2020","unstructured":"Mehrabadi S, Jahanian Sadatmahalleh S, Kazemnejad A, Moini A (2020) Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome: a cross-sectional study. Int J Reproduct BioMed (IJRM) 18(12):1049\u20131058. https:\/\/doi.org\/10.18502\/ijrm.v18i12.8026","journal-title":"Int J Reproduct BioMed (IJRM)"},{"key":"2117_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192214914","author":"FG Mirza","year":"2022","unstructured":"Mirza FG, Tahlak MA, Rjeili RB, Hazari K, Ennab F, Hodgman C, Khamis AH, Atiomo W, MDPI (2022) Polycystic Ovarian Syndrome (PCOS): does the challenge end at conception? Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph192214914","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2117_CR102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","volume":"44","author":"P Moghetti","year":"2021","unstructured":"Moghetti P, Tosi F, Springer Science and Business Media Deutschland GmbH (2021) Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest 44(2):233\u2013244. https:\/\/doi.org\/10.1007\/s40618-020-01351-0","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2117_CR103","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s43032-021-00546-x","volume":"28","author":"I Naumova","year":"2021","unstructured":"Naumova I, Castelo-Branco C, Casals G (2021a) Psychological issues and sexual function in women with different infertility causes: focus on polycystic ovary syndrome. Reprod Sci 28(10):2830\u20132838. https:\/\/doi.org\/10.1007\/s43032-021-00546-x","journal-title":"Reprod Sci"},{"issue":"7","key":"2117_CR104","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s43032-020-00394-1","volume":"28","author":"I Naumova","year":"2021","unstructured":"Naumova I, Castelo-Branco C, Kasterina I, Casals G (2021b) Quality of life in infertile women with polycystic ovary syndrome: a comparative study. Reprod Sci 28(7):1901\u20131909. https:\/\/doi.org\/10.1007\/s43032-020-00394-1","journal-title":"Reprod Sci"},{"issue":"4","key":"2117_CR105","doi-asserted-by":"publisher","first-page":"e106694","DOI":"10.5812\/IJEM.106694","volume":"18","author":"MSG Naz","year":"2020","unstructured":"Naz MSG, Dovom MR, Tehrani FR (2020) The menstrual disturbances in endocrine disorders: a narrative review. Int J Endocrinol Metabolism 18(4):e106694. https:\/\/doi.org\/10.5812\/IJEM.106694","journal-title":"Int J Endocrinol Metabolism"},{"key":"2117_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/J.CBI.2020.109093","volume":"324","author":"HR Nejabati","year":"2020","unstructured":"Nejabati HR, Samadi N, Shahnazi V, Mihanfar A, Fattahi A, Latifi Z, Bahrami-asl Z, Roshangar L, Nouri M (2020) Nicotinamide and its metabolite N1-methylnicotinamide alleviate endocrine and metabolic abnormalities in adipose and ovarian tissues in rat model of Polycystic Ovary Syndrome. Chem Biol Interact 324:109093. https:\/\/doi.org\/10.1016\/J.CBI.2020.109093","journal-title":"Chem Biol Interact"},{"issue":"4","key":"2117_CR107","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.numecd.2022.01.003","volume":"32","author":"O Nemchikova","year":"2022","unstructured":"Nemchikova O, Frontoni S, Elsevier B.V (2022) The role of dietitian in the multidisciplinary treatment of PCOS. Nutr Metab Cardiovasc Dis 32(4):827\u2013832. https:\/\/doi.org\/10.1016\/j.numecd.2022.01.003","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2117_CR108","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12291-023-01130-7","volume":"39","author":"KU Nisa","year":"2024","unstructured":"Nisa KU, Tarfeen N, Mir SA, Waza AA, Ahmad MB, Ganai BA, Springer (2024) Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): a multifaceted hypothesis towards the disease with potential therapeutics. Indian J Clin Biochem 39(1):18\u201336. https:\/\/doi.org\/10.1007\/s12291-023-01130-7","journal-title":"Indian J Clin Biochem"},{"key":"2117_CR109","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/J.EJOGRB.2024.06.037","volume":"299","author":"M Nizamani","year":"2024","unstructured":"Nizamani M, Zaheer uddin M, Nagdev C, Ahmed N, Raza A (2024) Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 299:289\u2013295. https:\/\/doi.org\/10.1016\/J.EJOGRB.2024.06.037","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2117_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13040392","author":"S Novakovic","year":"2024","unstructured":"Novakovic S, Jakovljevic V, Jovic N, Andric K, Milinkovic M, Anicic T, Pindovic B, Kareva EN, Fisenko VP, Dimitrijevic A, Joksimovic Jovic J, Multidisciplinary Digital Publishing Institute (MDPI) (2024) Exploring the antioxidative effects of Ginger and Cinnamon: a comprehensive review of evidence and molecular mechanisms involved in Polycystic Ovary Syndrome (PCOS) and other oxidative stress-related disorders. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox13040392","journal-title":"Antioxidants (Basel)"},{"issue":"Issue 2","key":"2117_CR113","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/17446651.2021.1896966","volume":"16","author":"B Ozgen Saydam","year":"2021","unstructured":"Ozgen Saydam B, Yildiz BO, Taylor and Francis Ltd (2021) Weight management strategies for patients with PCOS: current perspectives. Expert Rev Endocrinol Metab 16(Issue 2):49\u201362. https:\/\/doi.org\/10.1080\/17446651.2021.1896966","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2117_CR114","doi-asserted-by":"publisher","unstructured":"Panchpuri M, Painuli R, Kumar C (2025) Artificial intelligence in smart drug delivery systems: a step toward personalized medicine. In: RSC Pharmaceutics. Royal Society of Chemistry. https:\/\/doi.org\/10.1039\/d5pm00089k","DOI":"10.1039\/d5pm00089k"},{"key":"2117_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/J.ARR.2023.102086","volume":"92","author":"SP Panda","year":"2023","unstructured":"Panda SP, Kesharwani A, Singh GD, Prasanth D, Vatchavai BR, Kumari PVK, Panda SK, Mallick SP (2023) Impose of KNDy\/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer\u2019s disease: StAR actions in prevention of neuroendocrine dysfunction. Ageing Res Rev 92:102086. https:\/\/doi.org\/10.1016\/J.ARR.2023.102086","journal-title":"Ageing Res Rev"},{"issue":"Issue 1","key":"2117_CR116","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17446651.2021.1865152","volume":"16","author":"G Papadakis","year":"2021","unstructured":"Papadakis G, Kandaraki EA, Garidou A, Koutsaki M, Papalou O, Diamanti-Kandarakis E, Peppa M, Taylor and Francis Ltd (2021) Tailoring treatment for PCOS phenotypes. Expert Rev Endocrinol Metab 16(Issue 1):9\u201318. https:\/\/doi.org\/10.1080\/17446651.2021.1865152","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"2117_CR117","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/ijmr.IJMR_2497_19","volume":"156","author":"AD Patil","year":"2022","unstructured":"Patil AD, Vaidya RA, Begum S, Chauhan SL, Mukherjee S, Kokate PP, Joshi BN (2022) An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India. Indian J Med Res 156(3):449\u2013458. https:\/\/doi.org\/10.4103\/ijmr.IJMR_2497_19","journal-title":"Indian J Med Res"},{"key":"2117_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01516-x","author":"AS Pe\u00f1a","year":"2020","unstructured":"Pe\u00f1a AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, Garad R, Dabadghao P, Teede H (2020) Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. https:\/\/doi.org\/10.1186\/s12916-020-01516-x","journal-title":"BMC Med"},{"issue":"4","key":"2117_CR119","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1017\/S0007114521003585","volume":"128","author":"IM Perovic Blagojevic","year":"2022","unstructured":"Perovic Blagojevic IM, Vekic JZ, MacUt DP, Ignjatovic SD, Miljkovic-Trailovic MM, Zeljkovic AR, Spasojevic-Kalimanovska VV, Bozic-Antic IB, Bjekic-Macut JD, Kastratovic-Kotlica BA, Andric ZG, Ilic DS, Kotur-Stevuljevic JM (2022) Overweight and obesity in polycystic ovary syndrome: association with inflammation, oxidative stress and dyslipidaemia. Br J Nutr 128(4):604\u2013612. https:\/\/doi.org\/10.1017\/S0007114521003585","journal-title":"Br J Nutr"},{"issue":"Issue 1","key":"2117_CR120","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.xfnr.2021.11.004","volume":"3","author":"P Phimphasone-Brady","year":"2022","unstructured":"Phimphasone-Brady P, Palmer B, Vela A, Johnson RL, Harnke B, Hoffecker L, Coons HL, Epperson CN, Elsevier Inc (2022) Psychosocial interventions for women with polycystic ovary syndrome: a systematic review of randomized controlled trials. F and S Rev 3(Issue 1):42\u201356. https:\/\/doi.org\/10.1016\/j.xfnr.2021.11.004","journal-title":"F and S Rev"},{"issue":"5","key":"2117_CR121","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/1747-0080.12670","volume":"78","author":"S Pirotta","year":"2021","unstructured":"Pirotta S, Joham AE, Moran LJ, Skouteris H, Lim SS (2021) Implementation of the polycystic ovary syndrome guidelines: a mixed method study to inform the design and delivery of a lifestyle management program for women with polycystic ovary syndrome. Nutr Diet 78(5):476\u2013486. https:\/\/doi.org\/10.1111\/1747-0080.12670","journal-title":"Nutr Diet"},{"key":"2117_CR122","doi-asserted-by":"publisher","first-page":"3419034","DOI":"10.1155\/2020\/3419034","volume":"2020","author":"M Pohanka","year":"2020","unstructured":"Pohanka M (2020) D-lactic acid as a metabolite: toxicology, diagnosis, and detection. BioMed Res Int 2020:3419034. https:\/\/doi.org\/10.1155\/2020\/3419034","journal-title":"BioMed Res Int"},{"key":"2117_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/J.PEC.2023.107771","volume":"113","author":"B Presswala","year":"2023","unstructured":"Presswala B, De Souza LR (2023) The diagnostic experience of polycystic ovary syndrome: a scoping review of patient perspectives. Patient Educ Couns 113:107771. https:\/\/doi.org\/10.1016\/J.PEC.2023.107771","journal-title":"Patient Educ Couns"},{"issue":"Issue 1","key":"2117_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","volume":"36","author":"F Ramezani Tehrani","year":"2020","unstructured":"Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E, Taylor and Francis Ltd (2020) Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol 36(Issue 1):12\u201323. https:\/\/doi.org\/10.1080\/09513590.2019.1650337","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2117_CR125","first-page":"569","volume":"60","author":"M Ram\u00f3n Garc\u00eda-S\u00e1enz","year":"2022","unstructured":"Ram\u00f3n Garc\u00eda-S\u00e1enz M, Ferreira-Hermosillo A, Lobaton-Ginsberg M, Clave P (2022) Proinflammatory cytokines in polycystic ovarian syndrome. Revista Med Del Instituto Mexicano Del Seguro Soc 60(5):569\u2013576","journal-title":"Revista Med Del Instituto Mexicano Del Seguro Soc"},{"key":"2117_CR209","doi-asserted-by":"publisher","unstructured":"Rani N, Kumar P, Mishra A, Sankuratri B, Sethi S, Gelada K, Tiwari H (2021) Efficacy of spironolactone in adult acne in polycystic ovary syndrome patients an original research. J Pharm Bioallied Sci 13(6):S1659\u2013S1663. https:\/\/doi.org\/10.4103\/jpbs.jpbs_391_21","DOI":"10.4103\/jpbs.jpbs_391_21"},{"issue":"1","key":"2117_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/J.PHYPLU.2021.100161","volume":"2","author":"R Rani","year":"2022","unstructured":"Rani R, Hajam YA, Kumar R, Bhat RA, Rai S, Rather MA (2022) A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS). Phytomedicine plus 2(1):100161. https:\/\/doi.org\/10.1016\/J.PHYPLU.2021.100161","journal-title":"Phytomedicine plus"},{"key":"2117_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04229-9","author":"VS Rao","year":"2023","unstructured":"Rao VS, Armour M, Cheema BS, Smith CA, Moran L, Perera RS, Lim S, Gupta S, De Manincor M, Vaidya R, Ee C (2023) Use of traditional and complementary medicine by ethnic Indian women living with polycystic ovary syndrome: a global survey. BMC Complement Med Ther. https:\/\/doi.org\/10.1186\/s12906-023-04229-9","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"2117_CR128","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/J.TJOG.2021.11.009","volume":"61","author":"R Rashid","year":"2022","unstructured":"Rashid R, Mir SA, Kareem O, Ali T, Ara R, Malik A, Amin F, Bader GN (2022) Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol 61(1):40\u201350. https:\/\/doi.org\/10.1016\/J.TJOG.2021.11.009","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"2","key":"2117_CR129","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/clinem\/dgab613","volume":"107","author":"C Riestenberg","year":"2022","unstructured":"Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R, Endocrine Society (2022) Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences. J Clin Endocrinol Metab 107(2):575\u2013585. https:\/\/doi.org\/10.1210\/clinem\/dgab613","journal-title":"J Clin Endocrinol Metab"},{"key":"2117_CR130","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15318.1","author":"AL Rocha","year":"2019","unstructured":"Rocha AL, Oliveira FR, Azevedo RC, Silva VA, Peres TM, Candido AL, Gomes KB, Reis FM, F1000 Research Ltd (2019) Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.15318.1","journal-title":"F1000Res"},{"key":"2117_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103665","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, Bernardinelli L, Gasparri C, Peroni G, Perna S (2021) Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a one-group pretest\u2013post-test explanatory study. Nutrients. https:\/\/doi.org\/10.3390\/nu13103665","journal-title":"Nutrients"},{"key":"2117_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020583","author":"HM Sadeghi","year":"2022","unstructured":"Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M, MDPI (2022) Polycystic Ovary Syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23020583","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2117_CR133","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/deac091","volume":"37","author":"S Safiri","year":"2022","unstructured":"Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, Collins GS, Kolahi AA, Avery J (2022) Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019. Hum Reprod 37(8):1919\u20131931. https:\/\/doi.org\/10.1093\/humrep\/deac091","journal-title":"Hum Reprod"},{"key":"2117_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLMET.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/J.MOLMET.2020.01.001","journal-title":"Mol Metab"},{"issue":"2","key":"2117_CR135","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17446651.2023.2299400","volume":"19","author":"K Sardana","year":"2024","unstructured":"Sardana K, Muddebihal A, Sehrawat M, Bansal P, Khurana A, Taylor and Francis Ltd (2024) An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert Rev Endocrinol Metab 19(2):111\u2013128. https:\/\/doi.org\/10.1080\/17446651.2023.2299400","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2117_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061305","author":"G Scarf\u00f2","year":"2022","unstructured":"Scarf\u00f2 G, Daniele S, Fusi J, Gesi M, Martini C, Franzoni F, Cela V, Artini PG, MDPI (2022) Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines10061305","journal-title":"Biomedicines"},{"issue":"12","key":"2117_CR137","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.22038\/ijbms.2019.14029","volume":"22","author":"Z Shaaban","year":"2019","unstructured":"Shaaban Z, Khoradmehr A, Amiri-Yekta A, Shirazi MRJ, Tamadon A (2019) Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci 22(12):1378\u20131386. https:\/\/doi.org\/10.22038\/ijbms.2019.14029","journal-title":"Iran J Basic Med Sci"},{"key":"2117_CR138","doi-asserted-by":"publisher","unstructured":"Shah T, Lieman HJ (2022) Managing the PCOS-related symptoms of hirsutism, acne, and female pattern hair loss. In Polycystic Ovary Syndrome: Current and Emerging Concepts, pp. 205\u2013231. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-92589-5_11","DOI":"10.1007\/978-3-030-92589-5_11"},{"issue":"7","key":"2117_CR139","doi-asserted-by":"publisher","first-page":"e14117","DOI":"10.1111\/jfbc.14117","volume":"46","author":"R Shahid","year":"2022","unstructured":"Shahid R, Iahtisham-Ul-Haq M, Awan KA, Iqbal MJ, Munir H, Saeed I (2022) Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS). J Food Biochem 46(7):e14117. https:\/\/doi.org\/10.1111\/jfbc.14117","journal-title":"J Food Biochem"},{"key":"2117_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-023-01183-6","author":"J Shang","year":"2024","unstructured":"Shang J, Wang S, Wang A, Li F, Zhang J, Wang J, Lv R, Chen H, Mu X, Zhang K, Bai X, Tian Y (2024) Intra-ovarian inflammatory states and their associations with embryo quality in normal-BMI PCOS patients undergoing IVF treatment. Reprod Biol Endocrinol. https:\/\/doi.org\/10.1186\/s12958-023-01183-6","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"2117_CR141","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40291-023-00640-7","volume":"27","author":"A Sharma","year":"2023","unstructured":"Sharma A, Kumar R, Varadwaj P (2023) Smelling the disease: diagnostic potential of breath analysis. Mol Diagn Ther 27(3):321\u2013347. https:\/\/doi.org\/10.1007\/s40291-023-00640-7","journal-title":"Mol Diagn Ther"},{"key":"2117_CR142","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6619597","author":"W Shen","year":"2021","unstructured":"Shen W, Jin B, Pan Y, Han Y, You T, Zhang Z, Qu Y, Liu S, Zhang Y (2021) The effects of traditional Chinese medicine-associated complementary and alternative medicine on women with polycystic ovary syndrome. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2021\/6619597","journal-title":"Evid Based Complement Alternat Med"},{"issue":"11","key":"2117_CR143","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S (2022) A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet 39(11):2439\u20132473. https:\/\/doi.org\/10.1007\/s10815-022-02625-7","journal-title":"J Assist Reprod Genet"},{"key":"2117_CR144","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11681","author":"J Singh","year":"2020","unstructured":"Singh J, Wong H, Ahluwalia N, Go RM, Guerrero-Go MA (2020) Metabolic, hormonal, immunologic, and genetic factors associated with the incidence of thyroid disorders in polycystic ovarian syndrome patients. Cureus. https:\/\/doi.org\/10.7759\/cureus.11681","journal-title":"Cureus"},{"key":"2117_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJMCR.2024.100197","volume":"12","author":"S Singh","year":"2024","unstructured":"Singh S, Karmakar R, Pundir D, Singh A, Soni S, Vishwakarma M, Purohit A, Kashaw SK, Soni V (2024) Microneedles in cosmetology: a SWOT analysis. Eur J Med Chem Rep 12:100197. https:\/\/doi.org\/10.1016\/J.EJMCR.2024.100197","journal-title":"Eur J Med Chem Rep"},{"key":"2117_CR222","doi-asserted-by":"publisher","unstructured":"Sinha B, Ghosal S (2022) A meta-analysis of the effect of sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome. In: Frontiers in endocrinology, vol 13. Frontiers Media S.A. https:\/\/doi.org\/10.3389\/fendo.2022.830401","DOI":"10.3389\/fendo.2022.830401"},{"issue":"12","key":"2117_CR146","doi-asserted-by":"publisher","first-page":"948","DOI":"10.5603\/GP.a2021.0238","volume":"93","author":"K Skrzynska","year":"2022","unstructured":"Skrzynska K, Zachurzok A, Tomaszewski R, Gawlik A, Malecka-Tendera E (2022) The prevalence of autoimmune thyroiditis in adolescent girls with polycystic ovary syndrome. Ginekol Pol 93(12):948\u2013953. https:\/\/doi.org\/10.5603\/GP.a2021.0238","journal-title":"Ginekol Pol"},{"issue":"5","key":"2117_CR147","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s00404-024-07452-y","volume":"309","author":"M Sourouni","year":"2024","unstructured":"Sourouni M, Estermann J, Bitterlich N, Weidlinger S, Bachmann A, Stute P (2024) Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study. Arch Gynecol Obstet 309(5):2115\u20132126. https:\/\/doi.org\/10.1007\/s00404-024-07452-y","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"2117_CR148","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/J.FERTNSTERT.2021.10.024","volume":"117","author":"I Souter","year":"2022","unstructured":"Souter I, Sun F, Zhang H, Diamond MP, Legro RS, Wild RA, Hansen KR, Santoro N (2022) A personalized medicine approach to ovulation induction\/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertil Steril 117(2):408\u2013418. https:\/\/doi.org\/10.1016\/J.FERTNSTERT.2021.10.024","journal-title":"Fertil Steril"},{"key":"2117_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.698315","author":"B Soygur","year":"2021","unstructured":"Soygur B, Laird DJ (2021) Ovary development: insights from a three-dimensional imaging revolution. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.698315","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2117_CR150","doi-asserted-by":"publisher","first-page":"288","DOI":"10.23736\/s0026-4946.20.05861-2","volume":"72","author":"ME Street","year":"2020","unstructured":"Street ME, Cirillo F, Catellani C, Dauriz M, Lazzeroni P, Sartori C, Moghetti P (2020) Current treatment for polycystic ovary syndrome: focus on adolescence. Minerva Pediatr 72(4):288\u2013311. https:\/\/doi.org\/10.23736\/s0026-4946.20.05861-2","journal-title":"Minerva Pediatr"},{"issue":"2","key":"2117_CR151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.30841\/2708-8731.2.2021.232519","volume":"2021","author":"VG Syusyuka","year":"2021","unstructured":"Syusyuka VG, Sergienko MY, Makurina GI, Yershova OA, Chornenka AS (2021) Characteristics of phenotypes (clinical variants) of polycystic ovary syndrome in women of reproductive age. Reprod Health Woman 2021(2):27\u201331. https:\/\/doi.org\/10.30841\/2708-8731.2.2021.232519","journal-title":"Reprod Health Woman"},{"key":"2117_CR202","doi-asserted-by":"publisher","unstructured":"Szczesnowicz A, Szeliga A, Niwczyk O, Bala G, Meczekalski B (2023) Do GLP-1 analogs have a place in the treatment of PCOS? new insights and promising therapies. In: Journal of clinical medicine, vol 12, no. 18. Multidisciplinary Digital Publishing Institute (MDPI). https:\/\/doi.org\/10.3390\/jcm12185915","DOI":"10.3390\/jcm12185915"},{"issue":"2","key":"2117_CR152","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","volume":"189","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE, Arlt W, Azziz R, Balen A, Bedson L, Berry L, Boivin J, Boyle J, Brennan L, Brown W, Burgert T, Busby M, Ee C, Garad RM, Gibson-Helm M, Harrison C, Hart R, Hopkins K, Hirschberg AL, Ho T, Hoeger K, Jordan C, Legro RS, Li R, Lujan M, Ma R, Mansfield D, Marsh K, Mocanu E, Mol B, Mormon R, Norman R, Oberfield S, Patel M, Pattuwage L, Pe\u00f1a A, Redman L, Rombauts L, Romualdi D, Shah D, Spritzer PM, Stener-Victorin E, Tehrani FR, Thangaratinam S, Thondan M, Vanky E, Wijeyaratne C, Witchel S, Yang D, Yildiz B, Alesi S, Alur-Gupta S, Avery J, Khomami MB, Benham J, Bidstrup H, Chua SJ, Cooney L, Coster T, Fitz V, Flanagan M, Forslund M, Jiskoot G, Kazemi M, Kempegowda P, Louwers Y, Melin J, Melson E, Mengistu YB, Naderpoor N, Neven A, Pastoor H, Rocha T, Sabag A, Subramanian A, Tan K (2023) Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 189(2):G43\u2013G64. https:\/\/doi.org\/10.1093\/ejendo\/lvad096","journal-title":"Eur J Endocrinol"},{"key":"2117_CR153","doi-asserted-by":"publisher","first-page":"4579831","DOI":"10.1155\/2022\/4579831","volume":"2022","author":"K U\u00e7kan","year":"2022","unstructured":"U\u00e7kan K, Demir H, Turan K, Sar\u0131kaya E, Demir C (2022) Role of oxidative stress in obese and nonobese PCOS patients. Int J Clin Pract 2022:4579831. https:\/\/doi.org\/10.1155\/2022\/4579831","journal-title":"Int J Clin Pract"},{"issue":"1","key":"2117_CR154","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/GRF.0000000000000596","volume":"64","author":"K Walker","year":"2021","unstructured":"Walker K, Decherney AH, Saunders R (2021) Menstrual dysfunction in PCOS. Clin Obstet Gynecol 64(1):119\u2013125. https:\/\/doi.org\/10.1097\/GRF.0000000000000596","journal-title":"Clin Obstet Gynecol"},{"key":"2117_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16233","author":"B Wang","year":"2023","unstructured":"Wang B, Li Z (2023) Hypersecretion of basal luteinizing hormone and an increased risk of pregnancy loss among women with polycystic ovary syndrome undergoing controlled ovarian stimulation and intrauterine insemination. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16233","journal-title":"Heliyon"},{"key":"2117_CR156","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.12659\/MSM.901194","volume":"23","author":"LL Wang","year":"2017","unstructured":"Wang LL, Qi HB, Baker PN, Zhen QN, Zeng Q, Shi R, Tong C, Ge Q (2017) Altered circulating inflammatory cytokines are associated with anovulatory polycystic ovary syndrome (PCOS) women resistant to clomiphene citrate treatment. Med Sci Monit 23:1083\u20131089. https:\/\/doi.org\/10.12659\/MSM.901194","journal-title":"Med Sci Monit"},{"key":"2117_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/nu13103526","author":"Z Wang","year":"2021","unstructured":"Wang Z, Groen H, Cantineau AEP, van Elten TM, Karsten MDA, van Oers AM, Mol BWJ, Roseboom TJ, Hoek A (2021) Dietary intake, eating behavior, physical activity, and quality of life in infertile women with PCOS and obesity compared with non-PCOS obese controls. Nutrients. https:\/\/doi.org\/10.3390\/nu13103526","journal-title":"Nutrients"},{"key":"2117_CR158","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2147\/ijwh.s481509","volume":"16","author":"L Wang","year":"2024","unstructured":"Wang L, Wei W, Cai M (2024) A review of the risk factors associated with endometrial hyperplasia during perimenopause. Int J Womens Health 16:1475\u20131482. https:\/\/doi.org\/10.2147\/ijwh.s481509","journal-title":"Int J Womens Health"},{"key":"2117_CR205","doi-asserted-by":"publisher","unstructured":"Wasim T, Nasrin T, Zunair J, Irshad S (2024) Efficacy of Letrozole vs Clomiphene Citrate for induction of ovulation in women with polycystic ovarian syndrome. Pak J Med Sci 40(1). https:\/\/doi.org\/10.12669\/pjms.40.1.7971","DOI":"10.12669\/pjms.40.1.7971"},{"key":"2117_CR159","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9240569","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J (2022) Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature. J Healthcare Eng. https:\/\/doi.org\/10.1155\/2022\/9240569","journal-title":"J Healthcare Eng"},{"key":"2117_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.788772","author":"Z Xue","year":"2021","unstructured":"Xue Z, Li J, Feng J, Han H, Zhao J, Zhang J, Han Y, Wu X, Zhang Y (2021) Research progress on the mechanism between polycystic ovary syndrome and abnormal endometrium. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2021.788772","journal-title":"Front Physiol"},{"key":"2117_CR161","doi-asserted-by":"publisher","first-page":"744628","DOI":"10.3389\/fendo.2021.744628","volume":"12","author":"R Ye","year":"2021","unstructured":"Ye R, Yan C, Zhou H, Huang Y, Dong M, Zhang H, Jiang X, Yuan S, Chen L, Jiang R, Cheng Z, Zheng K, Zhang Q, Jin W (2021) Brown adipose tissue activation by cold treatment ameliorates polycystic ovary syndrome in rat. Front Endocrinol 12:744628. https:\/\/doi.org\/10.3389\/fendo.2021.744628","journal-title":"Front Endocrinol"},{"key":"2117_CR162","doi-asserted-by":"publisher","first-page":"740377","DOI":"10.3389\/fendo.2021.740377","volume":"12","author":"T Yu","year":"2021","unstructured":"Yu T, Wu D, Cao Y, Zhai J (2021) Association between menstrual patterns and adverse pregnancy outcomes in patients with polycystic ovary syndrome. Front Endocrinol 12:740377. https:\/\/doi.org\/10.3389\/fendo.2021.740377","journal-title":"Front Endocrinol"},{"key":"2117_CR163","doi-asserted-by":"publisher","first-page":"970733","DOI":"10.3389\/fendo.2022.970733","volume":"13","author":"J Yu","year":"2023","unstructured":"Yu J, Zhou Y, Ding J, Zhang D, Yu C, Huang H (2023) Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome. Front Endocrinol 13:970733. https:\/\/doi.org\/10.3389\/fendo.2022.970733","journal-title":"Front Endocrinol"},{"key":"2117_CR164","doi-asserted-by":"publisher","DOI":"10.29252\/ijrm.15.6.375","author":"F Zafari Zangeneh","year":"2017","unstructured":"Zafari Zangeneh F, Mehdi Naghizadeh M, Masoumi M (2017) Polycystic ovary syndrome and circulating inflammatory markers. Int J Reprod Biomed. https:\/\/doi.org\/10.29252\/ijrm.15.6.375","journal-title":"Int J Reprod Biomed"},{"issue":"1","key":"2117_CR165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1515\/openhe-2022-0008","volume":"3","author":"M Zehravi","year":"2022","unstructured":"Zehravi M, Maqbool M, Ara I (2022) Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review. Open Health 3(1):60\u201365. https:\/\/doi.org\/10.1515\/openhe-2022-0008","journal-title":"Open Health"},{"key":"2117_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.874914","author":"LH Zeng","year":"2022","unstructured":"Zeng LH, Rana S, Hussain L, Asif M, Mehmood MH, Imran I, Younas A, Mahdy A, Al-Joufi FA, Abed SN (2022) Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.874914","journal-title":"Front Pharmacol"},{"key":"2117_CR167","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fcell.2019.00382","volume":"7","author":"PY Zhang","year":"2020","unstructured":"Zhang PY, Yu Y (2020) Precise personalized medicine in gynecology cancer and infertility. Front Cell Dev Biol 7:382. https:\/\/doi.org\/10.3389\/fcell.2019.00382","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2117_CR168","doi-asserted-by":"publisher","first-page":"559.e1","DOI":"10.1016\/J.AJOG.2020.04.004","volume":"223","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ho K, Keaton JM, Hartzel DN, Day F, Justice AE, Josyula NS, Pendergrass SA, Actkins KE, Davis LK, Velez Edwards DR, Holohan B, Ramirez A, Stanaway IB, Crosslin DR, Jarvik GP, Sleiman P, Hakonarson H, Williams MS, Lee MTM (2020) A genome-wide association study of polycystic ovary syndrome identified from electronic health records. Am J Obstet Gynecol 223(4):559.e1-559.e21. https:\/\/doi.org\/10.1016\/J.AJOG.2020.04.004","journal-title":"Am J Obstet Gynecol"},{"key":"2117_CR169","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.REPROTOX.2022.05.002","volume":"111","author":"C Zhang","year":"2022","unstructured":"Zhang C, Xu L, Zhao Y, Wang Y (2022) Changes in serum heavy metals in polycystic ovary syndrome and their association with endocrine, lipid-metabolism, inflammatory characteristics and pregnancy outcomes. Reprod Toxicol 111:20\u201326. https:\/\/doi.org\/10.1016\/J.REPROTOX.2022.05.002","journal-title":"Reprod Toxicol"},{"key":"2117_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14291","author":"B Zhang","year":"2023","unstructured":"Zhang B, Yao X, Zhong X, Hu Y, Xu J (2023a) Vitamin D supplementation in the treatment of polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14291","journal-title":"Heliyon"},{"key":"2117_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1085656","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang W, Zhao J, Jiao P, Zeng L, Zhang H, Zhao Y, Shi L, Hu H, Luo L, Fukuzawa I, Li D, Li R, Qiao J (2023b) Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.1085656","journal-title":"Front Endocrinol"},{"issue":"2","key":"2117_CR172","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s42000-023-00438-6","volume":"22","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wang H, Ma Q, Liu Y, Chen A, Lu J, Ren L (2023c) Value of the triglyceride\u2013glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome. Hormones (Athens) 22(2):263\u2013271. https:\/\/doi.org\/10.1007\/s42000-023-00438-6","journal-title":"Hormones (Athens)"},{"key":"2117_CR173","doi-asserted-by":"publisher","first-page":"659268","DOI":"10.3389\/fendo.2021.659268","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Feng X, Zhao X, Jiang Y, Li X, Niu J, Meng X, Wu J, Xu G, Hou L, Wang Y (2021) How to screen and prevent metabolic syndrome in patients of PCOS early: implications from metabolomics. Front Endocrinol 12:659268. https:\/\/doi.org\/10.3389\/fendo.2021.659268","journal-title":"Front Endocrinol"},{"key":"2117_CR174","doi-asserted-by":"publisher","first-page":"822079","DOI":"10.3389\/fcvm.2022.822079","volume":"9","author":"C Zhuang","year":"2022","unstructured":"Zhuang C, Luo X, Wang W, Sun R, Qi M, Yu J (2022) Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis. Front Cardiovascular Med. 9:822079. https:\/\/doi.org\/10.3389\/fcvm.2022.822079","journal-title":"Front Cardiovascular Med."}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02117-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02117-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02117-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:12:34Z","timestamp":1771636354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02117-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":181,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02117-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}